| MODERNA INC. DL-,0001 |
| USA |
| Gesundheit |
| US60770K1079 / A2N9D9 |
| 0QF (Frankfurt) / MRNA (NASDAQ) |
| FRA:0QF, ETR:0QF, 0QF:GR, NASDAQ:MRNA |
| https://www.modernatx.com.. |
|
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, r..
>Volltext.. |
| 81999.06 Mio. EUR |
| 81165.12 Mio. EUR |
| 2290.85 Mio. EUR |
| -2425.13 Mio. EUR |
| -2530.37 Mio. EUR |
| -6.41 EUR |
| 3836.84 Mio. EUR |
| 1084.19 Mio. EUR |
| -1619.47 Mio. EUR |
| 2.55 |
| 17.18% |
| 7.29% |
| - |
| - |
| - |
| - |
| MODERNA |
| 17.11.26 |
|
||||
|
||||
|
||||
|
||||
|